Fiani B, Quadri SA, Cathel A, Farooqui M, Ramachandran A, Siddiqi I, et al. Esthesioneuroblastoma: A Comprehensive Review of Diagnosis, Management, and Current Treatment Options. World Neurosurg. 2019 Jun. 126:194-211. [QxMD MEDLINE Link].
Limaiem F, M Das J. Esthesioneuroblastoma. 2021 Jan. [QxMD MEDLINE Link]. [Full Text].
Guled M, Myllykangas S, Frierson HF Jr, Mills SE, Knuutila S, Stelow EB. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol. 2008 Jun. 21(6):770-8. [QxMD MEDLINE Link].
Mhawech P, Berczy M, Assaly M, Herrmann F, Bouzourene H, Allal AS, et al. Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract. Am J Clin Pathol. 2004 Jul. 122(1):100-5. [QxMD MEDLINE Link]. [Full Text].
Carney ME, O''Reilly RC, Sholevar B. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma). J Neurooncol. 1995 Oct. 26(1):35-43. [QxMD MEDLINE Link].
Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997 Jul-Aug. 17(4A):2683-706. [QxMD MEDLINE Link].
Carey RM, Godovchik J, Workman AD, Kuan EC, Parasher AK, Chen J, et al. Patient, disease, and treatment factors associated with overall survival in esthesioneuroblastoma. Int Forum Allergy Rhinol. 2017 Dec. 7 (12):1186-1194. [QxMD MEDLINE Link].
Theilgaard SA, Buchwald C, Ingeholm P. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol. 2003 Apr. 123(3):433-9. [QxMD MEDLINE Link].
Zhang M, Zhou L, Wang DH, Huang WT, Wang SY. Diagnosis and management of esthesioneuroblastoma. ORL J Otorhinolaryngol Relat Spec. 2010. 72(2):113-8. [QxMD MEDLINE Link].
Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, et al. Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg. 2010 Aug. 113(2):340-51. [QxMD MEDLINE Link].
Magnavita N, Sacco A, Bevilacqua L, D'Alessandris T, Bosman C. Aesthesioneuroblastoma in a woodworker. Occup Med (Lond). 2003 May. 53(3):231-4. [QxMD MEDLINE Link].
Peckham ME, Wiggins RH 3rd, Orlandi RR, Anzai Y, Finke W, Harnsberger HR. Intranasal Esthesioneuroblastoma: CT Patterns Aid in Preventing Routine Nasal Polypectomy. AJNR Am J Neuroradiol. 2017 Dec 7. [QxMD MEDLINE Link].
Tseng J, Michel MA, Loehrl TA. Peripheral cysts: a distinguishing feature of esthesioneuroblastoma with intracranial extension. Ear Nose Throat J. 2009 Jun. 88(6):E14. [QxMD MEDLINE Link].
Rostomily RC, Elias M, Deng M, Elias P, Born DE, Muballe D, et al. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression. Head Neck. 2006 Apr. 28(4):305-12. [QxMD MEDLINE Link].
Min KW. Usefulness of electron microscopy in the diagnosis of "small" round cell tumors of the sinonasal region. Ultrastruct Pathol. 1995 Sep-Oct. 19(5):347-63. [QxMD MEDLINE Link].
Argani P, Perez-Ordonez B, Xiao H. Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol. 1998 Apr. 22(4):391-8. [QxMD MEDLINE Link].
Hyams VJ, Batsakis JG, Michaels L. Olfactory neuroblastoma. In: Tumors of the Upper Respiratory Tract and Ear, Atlas of Tumor Pathology. Vol 25. Washington DC: Armed Forces Institute Press; 1988:. 240-8.
Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976 Mar. 37(3):1571-6. [QxMD MEDLINE Link].
Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993 May. 32(5):706-14; discussion 714-5. [QxMD MEDLINE Link].
Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope. 1992 Aug. 102(8):843-9. [QxMD MEDLINE Link].
Sun M, Wang K, Qu Y, Zhang J, Zhang S, Chen X, et al. Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis. Head Neck. 2021 Apr. 43 (4):1097-1104. [QxMD MEDLINE Link].
De Bonnecaze G, Lepage B, Rimmer J, Al Hawat A, Vairel B, Serrano E, et al. Long-term carcinologic results of advanced esthesioneuroblastoma: a systematic review. Eur Arch Otorhinolaryngol. 2016 Jan. 273 (1):21-6. [QxMD MEDLINE Link].
Zeng Q, Tian Y, He Y, Xie Q, Ou L, Wang M, et al. Long-Term Survival Outcomes and Treatment Experience of 64 Patients With Esthesioneuroblastoma. Front Oncol. 2021. 11:624960. [QxMD MEDLINE Link].
Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001 Nov. 2(11):683-90. [QxMD MEDLINE Link].
Fitzek MM, Thornton AF, Varvares M. Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer. 2002 May 15. 94(10):2623-34. [QxMD MEDLINE Link].
Nichols AC, Chan AW, Curry WT, Barker FG, Deschler DG, Lin DT. Esthesioneuroblastoma: the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. Skull Base. 2008 Sep. 18(5):327-37. [QxMD MEDLINE Link]. [Full Text].
Madani I, Bonte K, Vakaet L, Boterberg T, De Neve W. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys. 2009 Feb 1. 73(2):424-32. [QxMD MEDLINE Link].
Sterzing F, Stoiber EM, Nill S, Bauer H, Huber P, Debus J, et al. Intensity Modulated Radiotherapy (IMRT) in the treatment of children and adolescents - a single institution''s experience and a review of the literature. Radiat Oncol. 2009 Sep 23. 4(1):37. [QxMD MEDLINE Link]. [Full Text].
Tselis N, Heyd R, Baghi M, Zamboglou N. Interstitial high-dose-rate-brachytherapy in advanced esthesioneuroblastoma. Laryngoscope. 2008 Nov. 118(11):2006-10. [QxMD MEDLINE Link].
Gupta S, Husain N, Sundar S. Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: a case report. World J Surg Oncol. 2011 Oct 5. 9:118. [QxMD MEDLINE Link]. [Full Text].
Loy AH, Reibel JF, Read PW, Thomas CY, Newman SA, Jane JA, et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg. 2006 Feb. 132(2):134-8. [QxMD MEDLINE Link].
McElroy EA Jr, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery. 1998 May. 42(5):1023-7; discussion 1027-8. [QxMD MEDLINE Link].
Porter AB, Bernold DM, Giannini C, Foote RL, Link MJ, Olsen KD, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol. 2008 Nov. 90(2):201-4. [QxMD MEDLINE Link].
Koka VN, Julieron M, Bourhis J. Aesthesioneuroblastoma. J Laryngol Otol. 1998 Jul. 112(7):628-33. [QxMD MEDLINE Link].
Mishima Y, Nagasaki E, Terui Y, Irie T, Takahashi S, Ito Y, et al. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma. Cancer. 2004 Sep 15. 101(6):1437-44. [QxMD MEDLINE Link]. [Full Text].
Turano S, Mastroianni C, Manfredi C, Biamonte R, Ceniti S, Liguori V, et al. Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine. J Neurooncol. 2010 May. 98(1):131-5. [QxMD MEDLINE Link].
Spengler M, Wheelden M, Mackley HB, Drabick JJ. Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation. JCO Precis Oncol. 2021. 5:[QxMD MEDLINE Link]. [Full Text].
Castelnuovo P, Bignami M, Delù G, Battaglia P, Bignardi M, Dallan I. Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience. Head Neck. 2007 Sep. 29(9):845-50. [QxMD MEDLINE Link].
Folbe A, Herzallah I, Duvvuri U, Bublik M, Sargi Z, Snyderman CH, et al. Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study. Am J Rhinol Allergy. 2009 Jan-Feb. 23(1):91-4. [QxMD MEDLINE Link].
Devaiah AK, Andreoli MT. Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients. Laryngoscope. 2009 Jul. 119(7):1412-6. [QxMD MEDLINE Link].
De Bonnecaze G, Chaput B, Al Hawat A, Filleron T, Vairel B, Serrano E, et al. Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma. Acta Otolaryngol. 2014 Dec. 134 (12):1259-64. [QxMD MEDLINE Link].
Barinsky GL, Azmy MC, Kilic S, Grube JG, Baredes S, Hsueh WD, et al. Comparison of Open and Endoscopic Approaches in the Resection of Esthesioneuroblastoma. Ann Otol Rhinol Laryngol. 2021 Feb. 130 (2):136-141. [QxMD MEDLINE Link].
Zanation AM, Ferlito A, Rinaldo A, Gore MR, Lund VJ, McKinney KA, et al. When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol. 2010 Nov. 267(11):1667-71. [QxMD MEDLINE Link]. [Full Text].
Beitler JJ, Fass DE, Brenner HA, Huvos A, Harrison LB, Leibel SA, et al. Esthesioneuroblastoma: is there a role for elective neck treatment?. Head Neck. 1991 Jul-Aug. 13(4):321-6. [QxMD MEDLINE Link].
Rosenthal DI, Barker JL, El-Naggar AK. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer. 2004 Dec 1. 101(11):2567-73.